Synchronization of the ovulation and copulation timings increased the number of in vivo fertilized oocytes in superovulated female mice

PLoS One. 2023 Feb 6;18(2):e0281330. doi: 10.1371/journal.pone.0281330. eCollection 2023.

Abstract

The number of sperm that reaches the oocytes in mammalian species is limited. In mice, 8-10 oocytes are ovulated, a similar number of sperm reaches the oocytes, and nearly all oocytes are fertilized via natural mating. Meanwhile, our improved superovulation technique (ultrasuperovulation: administration of inhibin antiserum and equine chorionic gonadotropin [IASe]) produced 100 oocytes from a single female C57BL/6 mouse but resulted in only approximately 20 fertilized oocytes via mating. We hypothesized that sperm shortage in the ampulla might cause this low fertilization rate. Mice were mated in the proestrus stage or after hormone injection, but ovulation timing was not considered. In clinical application, the rhythm method supports fertilization by testing the ovulation period and synchronizing the ovulation and copulation timings. Therefore, this study examined the effects of ovulation and copulation timings on in vivo fertilization in female mice with IASe. Synchronization of the ovulation and copulation timings increased fertilization efficiency in female mice with ultrasuperovulation. The number of embryos obtained post ovulation was three times higher than that obtained pre ovulation. This study suggests that synchronized ovulation and copulation timings improve the efficiency of in vivo fertilization in IASe-treated female mice. This technique can be used to produce genetically modified mice and develop technologies for infertility treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Copulation*
  • Female
  • Horses
  • Male
  • Mammals
  • Mice
  • Mice, Inbred C57BL
  • Oocytes
  • Ovulation
  • Semen*
  • Superovulation

Grants and funding

This research was supported by following organizations. TT, Research on Development of New Drugs [Project ID: 16769865], Japan Agency for Medical Research and Development https://www.amed.go.jp/en/index.html TT, Grant-in-Aid for Scientific Research (C) (KAKENHI) [Project ID: 20K07015], Japan Society for the Promotion of Science https://www.jsps.go.jp/english/index.html TT, Cooperative Research Programme, Institute for Frontier Life and Medical Sciences, Kyoto University https://www.infront.kyoto-u.ac.jp/en/kyoten/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.